(Press-News.org) Craniopharyngiomas account for 2–5% of all primary brain tumors and 5–10% of pediatric brain tumors. Despite their benign histology, their location near the hypothalamus, pituitary gland, and optic pathways complicates management. Gross total resection, while effective, carries high risks of visual, endocrine, and hypothalamic dysfunction. Adjuvant radiotherapy after subtotal resection offers comparable control with fewer complications, but conventional fractionated radiotherapy is associated with long-term risks such as cognitive decline, secondary malignancies, and vascular injury. SRS delivers highly conformal, high-dose radiation with rapid dose fall-off, making it especially suitable for CPs adjacent to critical structures. Platforms include Gamma Knife, CyberKnife, and linear accelerator (LINAC)-based systems, with fractionated SRT (FSRT) used for larger or less favorably located tumors.
SRS vs. Conventional Radiotherapy
While conventional radiotherapy (54–60 Gy over 5–6 weeks) remains a standard adjuvant treatment, it exposes surrounding tissues to significant radiation, increasing risks of stroke, secondary tumors, and neurocognitive deficits—particularly in pediatric patients. SRS, by contrast, minimizes radiation to healthy tissues. Meta-analyses show no significant difference in long-term progression-free survival or endocrine outcomes between SRS and conventional radiotherapy, but SRS is associated with a lower incidence of hypothalamic obesity and other long-term sequelae.
Treatment Outcomes by Modality
Gamma Knife Radiosurgery
Gamma Knife is the most extensively studied SRS modality for CP. Tumor control rates range from 36% to 100%, with higher rates (79.6–91.4%) achieved when marginal doses ≥12 Gy are used. Key factors influencing outcomes include:
Dose-Response: Doses below 10 Gy are associated with inferior control. A threshold of ≥12 Gy to ≥85% of the tumor volume optimizes local control.
Tumor Volume: Smaller tumors (<5 cm³ or diameter <19 mm) show better response and longer progression-free survival.
Tumor Composition: Solid tumors respond better than cystic or mixed lesions, which may require adjunctive therapies such intracavitary brachytherapy.
Long-term follow-up data indicate that control rates remain stable over time, with repeat SRS or combined approaches effective for recurrences.
CyberKnife and LINAC-Based SRS
CyberKnife offers frameless, fractionated treatment, making it suitable for tumors near the optic apparatus or those with significant cystic components. Preliminary studies report control rates of 69.8–93.75%, with the flexibility to adapt treatment to cyst dynamics. LINAC-based systems also support both single-fraction and fractionated regimens, particularly for larger or irregularly shaped tumors.
Safety and Complications
SRS demonstrates a favorable safety profile:
Visual Complications: Occur in ~4% of cases, primarily when the optic apparatus receives >10 Gy or is already compromised.
Endocrine Dysfunction: New deficits occur in ~6% of patients, often in those with pre-existing pituitary insufficiency.
Other Risks: Radiation necrosis and cognitive effects are rare. Maximum point doses >35 Gy may increase delayed neurological risks.
Dose constraints are critical, especially for the optic chiasm (tolerance: 8–10 Gy per fraction) and hypothalamus. In pediatric patients, stricter limits help preserve long-term quality of life.
Future Directions
Several areas warrant further investigation:
Dose and Fractionation Optimization: Refined protocols are needed for cystic, large, or recurrent tumors.
Molecular Targeting: BRAF mutations in papillary CPs open avenues for neoadjuvant targeted therapy (e.g., BRAF/MEK inhibitors) to shrink tumors before SRS.
Prospective Multicenter Trials: Standardized outcome measures and longer follow-up are essential to validate SRS efficacy and safety.
Quality of Life Metrics: Future studies should incorporate neurocognitive, endocrine, and psychosocial outcomes to fully assess the benefits of SRS.
Conclusion
Stereotactic radiosurgery is a cornerstone in the multidisciplinary management of craniopharyngioma, particularly for residual or recurrent disease. It offers high rates of tumor control with a favorable toxicity profile compared to conventional radiotherapy. Ongoing technical refinements, combined with molecular insights and personalized treatment planning, promise to further improve outcomes and quality of life for patients with this challenging tumor.
Full text:
https://xiahepublishing.com/3067-6150/NSSS-2025-00038
The study was recently published in the Neurosurgical Subspecialties.
Neurosurgical Subspecialties (NSSS) is the official scientific journal of the Department of Neurosurgery at Union Hospital of Tongji Medical College, Huazhong University of Science and Technology. NSSS aims to provide a forum for clinicians and scientists in the field, dedicated to publishing high-quality and peer-reviewed original research, reviews, opinions, commentaries, case reports, and letters across all neurosurgical subspecialties. These include but are not limited to traumatic brain injury, spinal and spinal cord neurosurgery, cerebrovascular disease, stereotactic radiosurgery, neuro-oncology, neurocritical care, neurosurgical nursing, neuroendoscopy, pediatric neurosurgery, peripheral neuropathy, and functional neurosurgery.
Follow us on X: @xiahepublishing
Follow us on LinkedIn: Xia & He Publishing Inc.
END
PULLMAN, Wash. – A Washington State University-led study in Guatemala found the sources of drinking water people believe to be safe and clean often contain potentially dangerous bacteria.
Focusing on the Western Highlands region of Guatemala, researchers examined how community perceptions of water safety compared with actual water quality. While residents overwhelmingly believed bottled water sold in large refillable jugs to be the safest option for drinking, researchers found that of 11 water sources tested it was the most frequently contaminated with coliform bacteria – an indicator of fecal contamination. ...
Move over, colonoscopies — researchers report in ACS Sensors that they’ve developed a sensor made of tiny microspheres packed with blood-sensing bacteria that detect markers of gastrointestinal disease. Taken orally, the miniature “pills” also contain magnetic particles that make them easy to collect from stool. Once excreted from mouse models with colitis, the bacterial sensor detected gastrointestinal bleeding within minutes. The researchers say the bacteria in the sensor could be adapted to detect other gut diseases.
“This ...
Jennifer Munson, a cancer researcher at Virginia Tech's Fralin Biomedical Research Institute at VTC, has been awarded two new National Institutes of Health grants to advance greater understanding and improved treatment of a deadly brain cancer.
While the grants from the National Cancer Institute fund different projects, both involve identifying how the movement of fluid surrounding tumor cells contributes to the spread of glioblastoma, a deadly brain tumor, into neighboring brain areas, allowing the cancer to return after surgery or radiation.
Munson and her team are identifying how liquid called interstitial fluid moves between ...
While many global road maps exist, few include detailed surface information or keep pace with rapid infrastructure change. The new HeiGIT dataset closes this gap by combining 3–4 meter resolution PlanetScope imagery (2020–2024) with deep-learning models to analyze 9.2 million kilometers of major transport routes connecting cities and rural regions. The result is a high-accuracy global classification (89.2%), outperforming widely used open datasets by over 20 percentage points.
A central component of the dataset is the Humanitarian Passability Score — an index that combines surface type and ...
Middle-aged Australians are keeping the country running - but it’s taking a hefty toll on their wellbeing, a new report shows.
‘A Balancing Act: Life, work and connection in the middle years’, the latest report by the Bankwest Curtin Economics Centre, finds Australians aged 35 to 55 are facing mounting pressures as they balance work, family and financial demands, with life satisfaction dipping to its lowest point in midlife.
Report lead and co-author Dr Daniel Kiely from the Bankwest Curtin Economics Centre, said while people ...
Why do the world’s most prestigious firms—such as McKinsey, Goldman Sachs and other elite consulting giants, investment banks, and law practices—hire the brightest talents, train them intensively, and then, after a few years, send many of them packing? A recent study in the American Economic Review concludes that so-called adverse selection is not a flaw but rather a sign that the system is working precisely as intended.
Two financial economists, from the University of Rochester and the University of Wisconsin–Madison respectively, created a model that explains how reputation, information, ...
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline such as memory loss and behavioral disturbances that severely impair quality of life. Despite decades of research, effective disease-modifying therapies remain elusive, underscoring the urgent need for novel neuroprotective strategies. Lithium (LIT), a well-known mood stabilizer for the treatment of bipolar disorder, shows neuroprotective effects, including inhibition of glycogen synthase kinase 3 beta, ...
Wiley, a global leader in authoritative content and research intelligence, today announced the release of additional data to its IR, Raman, LC-MS, and SmartSpectra libraries, significantly broadening compound coverage. The expansion brings Wiley's spectral database offerings to over 9.5 million high-quality spectra, delivering researchers enhanced capabilities for faster, more confident compound identification.
"These updates deliver what researchers need ...
COPENHAGEN (November 19, 2025)—New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, has the potential to improve tuberculosis (TB) treatment when combined with pretomanid and linezolid in a treatment regimen known as “SPaL.”
The NC-009 trial (a pan-Phase 2 clinical trial) showed that, overall, sorfequiline had greater activity than bedaquiline. The 100 mg SPaL regimen had greater activity against TB than the standard of care HRZE (isoniazid, rifampin, pyrazinamide, and ethambutol), indicating the potential ...
Antibiotic resistance is one of the most pressing challenges to global public health as harmful microbes evolve to evade these medications. Now, researchers at University of California San Diego and their colleagues have developed a new method to combat antibiotic-resistant bacteria using bacteriophages, or phages, for short — viruses that infect and kill bacteria — as an alternative to traditional antibiotics.
The researchers targeted Klebsiella pneumoniae, a species of bacteria notorious for its ability to resist multiple antibiotics. The dangerous pathogen can cause severe infections in hospital settings, including pneumonia and ...
